Posted on 4月 18, 20224/18/22
FDA Moves Cybersecurity Into the Product Life Cycle
Posted on 12月 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on 10月 12, 202110/12/21
WEBINAR: A Pivotal Shift in Life Sciences Industry Across R&D and Commercial: A Conversation with the Experts
Posted on 10月 5, 202110/5/21
WEBINAR: The New Path to European Pharmaceutical Commercialisation
Posted on 8月 27, 20218/27/21
Disrupting Healthcare from the Inside: How Incumbents Can Lead Change
Posted on 7月 26, 20217/26/21
Breaking through Barriers: Critical Success Factors for Launching Products with Breakthrough Therapy Designation
Posted on 7月 13, 20217/13/21
The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making
Posted on 7月 1, 20217/1/21
BLOG: Medical vs. Pharmacy Benefit: A Look at UM Differences
Posted on 6月 15, 20216/15/21
BLOG: Gaining Coverage for Emerging Medical Technologies
Posted on 6月 11, 20216/11/21